-
How could AI change drug development by ChatGPT
PharmaSources
February 26, 2024
Artificial Intelligence (AI) has the potential to significantly impact and revolutionize the field of drug development in several ways.
-
Global R&D Drug Development 2023: Overcoming Barriers, Bringing Hope to Patients and ESG focused
Shruti Talashi
January 02, 2024
As the global healthcare system refocuses after the pandemic, a recent report on the global R&D trend 2023 which was put together as a public service by the IQVIA Institute for Human Data Science.
-
Artificial Intelligence for Drug Development
David Orchard-Webb
July 31, 2023
Artificial Intelligence (AI) is making a significant impact in the pharmaceutical industry, revolutionizing various aspects of drug discovery, development, and healthcare.
-
Against Liver Cancer, Statins Helps Novel Liver Cancer Drug Development
Yuntian/PharmaSources
April 20, 2023
Statins help to improve liver cancer and have been confirmed by a large number of clinical and scientific trials.
-
Consistent Phase-Based Analytical Supports for NCE Drug Developments
PharmaSources/Eric Sun
March 10, 2022
Once has been discovered, it is the ultimate goal for all biopharmaceutical companies to develop and deliver the targeted medicine to the patients with the optimum timescale and minimum risk.
-
Advancing Generic Drug Development to Approval
Lin Zhang
October 22, 2021
The FDA continuously works to change and improve their work, including the work done with generic drugs. Last month, September 21-22, 2021, the Food and Drug Administration (FDA) hosted a workshop...
-
Alternative Method to Accelerate Drug Development
Lin Zhang
January 21, 2021
Drug development is an essential process in the pharmaceutical industry, however, it is also time-consuming and costly which contains preclinical, clinical and after-market.
-
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Drug Development
Lin Zhang
December 09, 2020
Artificial Intelligence (AI) is gaining traction across a variety of sectors. AI can be used for a variety of goals and is likely to become a staple in drug development, among other things.
-
Monoclonal Antibodies - The Challenges in Drug Development
Neeta Ratanghayra
July 28, 2020
Monoclonal antibodies (mAb) are approved in a wide range of conditions and represent the largest class of biotherapeutic products. mAbs are large molecules with complex structures and functions.
-
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development
B3C newswire
November 30, 2023
MIMETAS, a leader in human 3D disease modeling, and Yamaha Motor Co., Ltd., a developer of the CELL HANDLER™, announce a strategic joint marketing agreement